New Canadian Pharmaceutical Naming Process in Effect
By Frances M. Jagla
Health Canada, the country’s federal health department, has officially launched the new process for all pharmaceutical trademark submissions. The “Guidance Document for Industry-Review of Drug Brand Names” went into effect on June 13. From this point forward, all brand name submissions are expected to follow the revised process. Prior to the submission of a trademark/brand name to Health Canada, the submitting company must have conducted, at the very least, initial trademark name review, look-alike (visual similarity) review, sound-alike (phonetic similarity) review, simulation name studies, and Failure Mode and Effects Analysis (FMEA).
For more information, please contact the Intellectual Property and Technology Group at Lane Powell: